CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,089 enrolled
Drug / intervention
No treatment givenother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05317845
NCT05317845N/ACompleted
CompareCT.gov

A Multi-center, Cross-sectional Chart Review and Survey to Capture the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa

Novo Nordisk A/S·observational·Posted Apr 8, 2022·Updated Mar 28, 2023

In Brief

An observational study evaluating No treatment given for Diabetes Mellitus, Type 2. Completed, enrolled 4,089 participants across 7 sites in 7 countries.

Detailed Summary

The study is intended to estimate the proportion and clinical management of people with type 2 diabetes having atherosclerotic cardiovascular diseases or who are at high risk to develop atherosclerotic cardiovascular diseases. Participants will be asked to give information about their health. Partipants will continue normal way of life and will not get any medication other than those prescribed to them by the doctor. The study will last for about 6 months.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesBahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 8, 2022
Enrollment StartApr 21, 2022
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.2 years ago

Interventions

No treatment givenother

The clinical management and prescribed treatment of diabetes and eASCVD/ASCVD risk factors are independent of this study and are part of the routine clinical practice at the discretion of the treating physician.